Neuropsychopharmacology
- A preliminary study of the effects of an antimuscarinic agent on anxious behaviors and white matter microarchitecture in nonhuman primates2 years ago
- A unique role for cAMP signaling in microglia during opioid tolerance and withdrawal2 years ago
- Effect of selective serotonin reuptake inhibitor treatment following diagnosis of depression on suicidal behaviour risk: a target trial emulation2 years ago
- Correction: Ethical considerations in rapid and novel treatments in psychiatry2 years ago
- Integrating public health and translational basic science to address challenges of xylazine adulteration of fentanyl2 years ago
- Kynurenic acid: translational perspectives of a therapeutically targetable gliotransmitter2 years ago
- Control of dopamine communication by opioids: glutamate enters the discussion2 years ago
Journal of Psychopharmacology
- Developing a new national MDMA policy: Results of a multi-decision multi-criterion decision analysis5 years ago
- Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports5 years ago
- Does variation in trait schizotypy and frequency of cannabis use influence the acute subjective, cognitive and psychotomimetic effects of delta-9-tetrahydrocannabinol? A mega-analysis5 years ago
- Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice5 years ago
- Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD5 years ago
- Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity5 years ago
- Pharmacological uses of flumazenil in benzodiazepine use disorders: a systematic review of limited data5 years ago
European Neuropsychopharmacology
- Offspring studies: Predicting conversion to psychosis5 years ago
- Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions5 years ago
- Rating, berating or overrating antidepressant efficacy? The case of the Hamilton depression rating scale5 years ago
- Suicide in the COVID-19 pandemic: what we learnt and great expectations5 years ago
- Route map for machine learning in psychiatry: Absence of bias, reproducibility, and utility5 years ago
- Autoimmune encephalitis or autoimmune psychosis?5 years ago
- Pharmacokinetic and pharmacodynamic interactions between daridorexant, a dual orexin receptor antagonist, and citalopram in healthy subjects5 years ago